Related content

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

By Lalami Y.   Paesmans M.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

By Shikata Hisaharu   Yakushijin Yoshihiro   Yamanouchi Jun   Azuma Taichi   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 178-185

Springer Publishing Company

Access to resources Recommend Favorite

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis

By Grigull Lorenz   Pulver Nicole   Goudeva Lilia   Sykora Karl-Walter   Linderkamp Christin   Beilken Andreas   Seidemann Kathrin   Schmid Hansjörg   Welte Karl   Heuft Hans-Gert  

Supportive Care in Cancer, Vol. 14, Iss. 9, 2006-09 ,pp. : 910-916

Springer Publishing Company

Access to resources Recommend Favorite

Expression of G-CSF and GM-CSF in Human Meningiomas Correlates with Increased Tumor Proliferation and Vascularization

By Braun Bernhard   Lange Manfred   Oeckler Reinhard   Mueller Margareta  

Journal of Neuro-Oncology, Vol. 68, Iss. 2, 2004-06 ,pp. : 131-140

Springer Publishing Company

Access to resources Recommend Favorite